NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP
Pro-dex, Inc. PDEX
15 fiscal years on record · USD · FY2024 reported
SEC FILINGS ONLY
Revenue · FY2024
$66.6M
▲ 23.7% vs FY2023
EPS · FY24
$2.67
Dividend / sh · FY24
—
Payout · FY24
—
ROE · FY24
26.6%
Net margin · FY24
13.5%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 66.6M
Revenue, FY2024 · full 15-year series below
Revenue
Net income
13 cents of every revenue dollar became profit this year.
Per share
USD 2.67
Diluted EPS, FY2024
EPS
The company pays no cash dividend.
Profitability
26.6%
Return on equity, FY2024
ROE
Operating margin16.1%
Net margin13.5%
Return on assets15.8%
Each USD of equity produced 27 cents of profit this year.
Returned to shareholders
USD 3.5M
returned in FY2024 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 3.5M
Share of profit39.0%
Consecutive raises—
USD 3.5M in buybacks — 39% of the year's profit went back to shareholders.
Growth
+13.8% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+16.6%
+13.8%
+17.4%
Net income
+25.2%
+8.0%
EPS, diluted
+30.2%
+12.2%
Returned to shareholders
+29.7%
+0.7%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.00B
Shares outstanding, FY2024
Change, 5 years−14.4%
Change, 10 years−21.2%
The share count shrank 14% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 61.2M
total assets, end of FY2024
Total assetsUSD 61.2M
EquityUSD 36.6M
CashUSD 419,000.00
Gross debtUSD 15.4M
Net debtUSD 15.0M
Current ratio3.23×
Net debt stands at 41% of equity.
History
15 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Revenue $B
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
−0.0
−0.0
0.0
EBITDA $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
−0.0
−0.0
0.0
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
0.0
Net income $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
−0.0
−0.0
0.0
EPS, diluted $
2.67
0.60
1.95
1.21
1.57
1.50
0.97
0.37
1.25
0.20
−0.09
−0.14
−0.54
−0.27
0.80
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
26.6
6.8
24.8
19.6
30.7
33.9
24.2
10.5
45.0
9.5
−4.1
−5.7
−20.4
−8.8
25.6
Shares out B
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
60 of 60
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed